BIO 1x1 Partnering

@bio1x1

Connecting biotech & pharma companies with investors & potential partners.

Washington DC
Vrijeme pridruživanja: prosinac 2009.

Tweetovi

Blokirali ste korisnika/cu @bio1x1

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @bio1x1

  1. prije 6 sati

    Make sure to catch fireside chats from Barbara Dalton of and other key biotech and pharma leaders, including , ; Ted W. Love, ; Michael M. Morrissey, and Carol Lynch, at ! View the complete program⬇️

    Poništi
  2. proslijedio/la je Tweet

    Publishing 5th report on highly prevalent chronic disease tomorrow - hypertension & heart failure: 👇 Cardio overall: --Clinical success rates --VC funding --Pipeline growth by disease HT and HF: --Trial starts --Pipeline NCEs by phase --FDA approved MOAs

    Poništi
  3. prije 8 sati

    Download your copy of BIO’s first annual report on diversity and inclusion in biotechnology at

    Poništi
  4. prije 9 sati

    What's next in fighting solid tumors? Dr. Benjamin Cowen, CEO of , a clinical stage biotech company developing anti-tumor and immune-metabolism therapies, will speak about that and his impressive experience in biotech at .

    Poništi
  5. prije 10 sati

    BIO will be releasing a new Industry Analysis report tomorrow on hypertension and heart failure. Request your copy now and receive it via email when it becomes available:

    Poništi
  6. prije 12 sati

    See who you can meet at , the must-attend meeting for top investment firms in the region! More than 340 investors have already registered, including , and .

    Poništi
  7. proslijedio/la je Tweet
    29. sij

    Looking forward to this panel at BIO in a few weeks. Come along to hear more about communicating evidence of a therapy's value.

    Poništi
  8. prije 14 sati

    Thank you for providing scholarships to NYC’s innovative biotechs to attend and pitch investors. See you next week!

    Poništi
  9. 4. velj

    💡PANEL SPOTLIGHT💡 Catch the Market Performance and IPO Class of 2020 panel at and examine whether the overall market will experience a cooling off period in 2020 or if we are at the beginning of a long-term growth cycle. View the complete program⬇️

    Poništi
  10. 4. velj

    Download your copy of BIO’s first annual report on diversity and inclusion in biotechnology at

    Poništi
  11. proslijedio/la je Tweet
    25. sij

    Meet Shawn Tomasello – Speaker at :

    Poništi
  12. 4. velj

    The Syneos One team at Syneos Health is dedicated to delivering fully integrated solutions focused on cost, speed, and risk mitigation to increase an asset’s NPV. Schedule a meeting with us at to learn more.

    Poništi
  13. 4. velj

    BIO will be releasing a new Industry Analysis report Thursday on hypertension and heart failure. Request your copy now and receive it via email when it becomes available:

    Poništi
  14. 3. velj

    Download your copy of BIO’s first annual report on diversity and inclusion in biotechnology at

    Poništi
  15. 3. velj

    BIO will be releasing a new Industry Analysis report Thursday on hypertension and heart failure. Request your copy now and receive it via email when it becomes available:

    Poništi
  16. 3. velj

    Regional investors, including Mitsubishi UFJ Capital, MSQ Ventures, Shinsei Capital Partners Limited and Teijin Pharma Limited, will be looking for cross-border development at BIO Asia International Conference! See who you can partner with at ❕

    Poništi
  17. 2. velj

    Sign up for the BIO Boardlist to support our mission of promoting workforce development, diversity, and inclusion at

    Poništi
  18. 2. velj

    Syneos Health provides capital solutions for biotechs by connecting innovators with the ‘right’ capital sources, and works with both to maximize ROI in a strategic ‘end to end’ model. Schedule a meeting with the Syneos team at to learn more.

    Poništi
  19. 1. velj

    BIO is helping them fulfill that commitment by providing resources to help build a more inclusive and diverse workforce. Learn more at

    Poništi
  20. 31. sij

    The Syneos One team at Syneos Health optimizes product development, thus creating the potential for cost efficiencies, increased speed to market, and de-risking of investment dollars. Meet us at and learn more.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·